in this issue
EnviroTech :: Biotech
Amyris Secures $83.7 Million in Financing
3:08 PM MST | February 27, 2012 | Rebecca Coons
Amyris says it has secured $83.7 million in financing to fund working capital, two weeks after the company told investors it was having trouble maintaining peak yields and was scaling back efforts to ramp up production of farnesene, its first commercial product. The financing included a $58.7 million private placement of common stock and $25 million in aggregate principal amount of 3% senior unsecured notes due 2017. The private placement included existing Amyris investors Temasek Holdings, Total Gas & Power USA...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee